AstraZeneca and Oxford University's COVID-19 vaccine trials will restart

Pharmaceutical

After being suspended on Tuesday due to a recorded side effect in a patient in the UK, AstraZeneca and Oxford University's COVID-19 vaccine trials will restart.

“AstraZeneca and Oxford University's COVID-19 vaccine trials will restart.“

The university declared that the UK regulator, the Medicines and Healthcare Products Regulatory Agency outlined that it was safe to continue and that it was predictable that some participants will fall ill in large trials.

See all the latest jobs in Pharmaceutical
Return to news

More news

Related Jobs

Global Head of Segment Sales - OEM

* Zenopa Salary Guide.
£80,000-£110,000

UK - Europe - East Coast USA

The Head of Segment Sales for our global OEM market is one of these key leadership roles which will develop and drive delivery of our future success in the OEM segment.

Role details

Field Service Engineer

* Zenopa Salary Guide.
Speak to Adam

Oxfordshire

An opportunity to join and be apart of a private company which specialises in the design and supply of special apparatus for medical and pharmaceutical applications.

Role details

Tags

astra zeneca    oxford university    covid-19    vaccine    news